Financials
Financial year 2025
3SPHARMA from Lubbeek, company number BE0817889449, closed financial year 2025 with a result of € 74,387 after tax. For that financial year 3SPHARMA recorded a gross margin of € 203,724 and equity of € 362,775. Compared with financial year 2024, the result moved from € 55,785 to € 74,387. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2025.
€ 362,775
▲ 26% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 74,387
▲ 33% vs 2024
Profit after tax over the fiscal year.
€ 281,399
▲ 43% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 342,315.
People and assets in 2025
€ 48,747
▲ 56% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,391
▼ 43% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 197,393
▼ 19% vs 2024
€ 45,608 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 54,895
▼ 4% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 23,899
▲ 28% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 152,380 | € 158,101 | € 171,685 | € 203,724 | ▲ 19% |
| Profit after taxes | € 68,876 | € 54,055 | € 55,785 | € 74,387 | ▲ 33% |
| Equity | € 178,548 | € 232,603 | € 288,388 | € 362,775 | ▲ 26% |
| Total debts | € 450,651 | € 439,334 | € 364,897 | € 321,008 | ▼ 12% |
| Cash | € 181,067 | € 262,181 | € 196,786 | € 281,399 | ▲ 43% |
| Retained profit | € 159,948 | € 214,003 | € 267,928 | € 342,315 | ▲ 28% |
| Bank debt | € 337,903 | € 291,458 | € 244,489 | € 197,393 | ▼ 19% |
| Balance sheet total | € 629,199 | € 671,937 | € 653,285 | € 683,783 | ▲ 5% |
Key figures of 3SPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to 3SPHARMA?
What happened at 3SPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 74,387 (▲ 33% vs 2024). Source: NBB ↗
- New establishment in Bierbeek. KBO
- Dries Poppe became a director. NBB
- Martine Schoolmeesters became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 68,876 profit in 2022 to € 74,387 profit in 2025.
Paid € 119,386 in corporate taxes since 2022.
Best year ever: 2025, with € 74,387 profit.
A new publication or filing at 3SPHARMA? We notify you, reason included.
Follow 3SPHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind 3SPHARMA are Dries Poppe and Martine Schoolmeesters.
Directors
According to the 2025 annual accounts
Dries Poppe
Director
since 2009
Martine Schoolmeesters
Associate
since 2009
Establishments
Establishment units
Physical locations of this company
Hertogenlaan(LIN) 35
3210 Lubbeek
Bevekomsestraat 15
3360 Bierbeek
Active since 19 August 2009
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0817.889.449
- VAT number
- BE 0817.889.449
- Registered office
- Hertogenlaan(LIN) 35, 3210 Lubbeek
- Names & denominations
- 3SPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 August 2009
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten